Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CETRELIMAB for Transitional cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where CETRELIMAB was used for Transitional cell carcinoma.

Other Indications for CETRELIMAB

Prostate cancer (9) Prostate cancer metastatic (7)

Other Drugs Used for Transitional cell carcinoma

PEMBROLIZUMAB (1,951) ENFORTUMAB VEDOTIN-EJFV (1,179) GEMCITABINE (825) ATEZOLIZUMAB (788) CISPLATIN (672) ENFORTUMAB VEDOTIN (649) NIVOLUMAB (595) AVELUMAB (554) CARBOPLATIN (493) GEMCITABINE\GEMCITABINE (255)

Related Pages

CETRELIMAB Full Profile All Transitional cell carcinoma Drugs CETRELIMAB Demographics CETRELIMAB Timeline